Latest filing published 27 May 2022 for Creo Medical Group plc, €18k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.5%Entry £0.97 · Close at T+365 £0.25
- -62.3%Entry £1.74 · Close at T+365 £0.66
- -7.4%Entry £1.95 · Close at T+365 £1.80
- +35.3%Entry £1.33 · Close at T+365 £1.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles Spicer: trading record in brief
All filings by Charles Spicer on record concern Creo Medical Group plc. Between 6 August 2019 and 26 May 2022, the trades on record add up to 4 filings.
Purchases make up the whole of the open-market record (4 purchases, €115k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 1 purchase and no sales on the market.
The median purchase comes to €21k. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 4 purchases with a full 90-day history, the hit rate stands at 25% and the median 90-day move at -22.6%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 27 May 2022, the filings show an open-market purchase worth €18k in Creo Medical Group plc. Filings reach the RNS (LSE) feed a median of 1 day after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Spicer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,435 shares@ £0.971815.4% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:4385348-0Canonical exit: 24 Aug 2022 (T+90)
- 9,657 shares@ £1.82517.9% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:4105227Canonical exit: 6 Dec 2021 (T+90)
- 24,509 shares@ £2.04100.0% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:3666683Canonical exit: 22 Oct 2020 (T+90)
- 14,220 shares@ £1.406428.3% of flowLondon Stock ExchangeISIN GB00BZ1BLL44FCA-NSM:LSE20190807135753_14180319_20200326185058613_33556Canonical exit: 4 Nov 2019 (T+90)
4 of 4 declarations